NCT06471686View on ClinicalTrials.gov

Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

July 30, 2023

Study Completion Date

October 30, 2023

Conditions
Alcohol Use DisorderLiver Transplant; Complications
Interventions
DRUG

Acamprosate

2 pills three times a day

Trial Locations (1)

90033

University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT06471686 - Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations | Biotech Hunter | Biotech Hunter